June 3, 2020
Myeloma Australia’s Medical and Scientific Advisory Group (MSAG)┬ápresents the article of the week. Lenalidomide, bortezomib, and dexamethasone (RVd) followed by autologous stem cell transplantation (ASCT) is standard frontline therapy for transplant-eligible patients with newly diagnosed multiple myeloma (NDMM). This study evaluated addition of daratumumab (D) to RVd in ASCTeligible NDMM patients. Patients (N=207) were randomized...
Continue Reading

Floor 7, 90 The Terrace
Wellington Central
New Zealand